Christos Sachpekidis, Jens Hillengass, Hartmut Goldschmidt, Hoda Anwar, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss: Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma. Am J Nucl Med Mol Imaging 2017;7(4):148-156. (Full text, PDF)
Lance T Hall, Benjamin Titz, H Ian Robins, Bryan P Bednarz, Scott B Perlman, Jamey P Weichert, John S Kuo: PET/CT imaging of the diapeutic alkylphosphocholine analog 124I-CLR1404 in high and low-grade brain tumors. Am J Nucl Med Mol Imaging 2017;7(4):157-166. (Full text, PDF)
Jacob Horsager, Susanne Bach Lausten, Dirk Bender, Ole Lajord Munk, Susanne Keiding: Hepatic metabolism of 11C-methionine and secretion of 11C-protein measured by PET in pigs. Am J Nucl Med Mol Imaging 2017;7(4):167-173. (Full text, PDF)
Ayse Tuba Kendi, David Brandon, Jeffrey Switchenko, Jeffery Trad Wadsworth, Mark W El-Deiry, Nabil F Saba, David M Schuster, Rathan M Subramaniam: Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study. Am J Nucl Med Mol Imaging 2017;7(4):174-180. (Full text, PDF)
Angela Spanu, Orazio Schillaci, Bastiana Piras, Diego F Calvisi, Antonio Falchi, Roberta Danieli, Susanna Nuvoli, Franca Dore, Giuseppe Madeddu: Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study. Am J Nucl Med Mol Imaging 2017;7(4):181-194. (Full text, PDF)
Liza Lindenberg, Stephen Adler, Ismail B Turkbey, Francesca Mertan, Anita Ton, Khanh Do, Shivaani Kummar, Esther Mena Gonzalez, Sibaprasad Bhattacharyya, Paula M Jacobs, Peter Choyke: Dosimetry and first human experience with 89Zr-panitumumab. Am J Nucl Med Mol Imaging 2017;7(4):195-203. (Full text, PDF)
